Axillary surgery in breast cancer management - Background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures

被引:19
作者
Blichert-Toft, M [1 ]
机构
[1] Rigshosp 3104, Dept Endocrine & Breast Surg, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1080/028418600750013005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prime objectives of axillary surgery in the management of breast cancer are 1) accurate staging, 2) treatment to cure and 3) quantitative information of metastatic lymph nodes for prognostic purposes and allocation to adjuvant protocols. It is generally agreed that axillary node status in potentially curable breast cancer is considered the single best predictor of outcome and the main determinant of allocation to adjuvant therapy. No physical examination, no imaging techniques, and no molecular biologic markers can today replace axillary surgery For staging purposes. The objectives of axillary surgery are best obtained by carrying out a complete axillary clearance. Nonetheless, less radical surgery is generally performed by carrying out a sampling procedure with a yield of about 4 nodes or a partial axillary dissection level I-II with at least 10 nodes recovered. Understaging the axilla is detrimental to outcome and, furthermore, locoregional tumor control is important for survival. Axillary surgery should therefore be conducted in accordance with high professional standards.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 43 条
[1]   REGIONAL TRENDS IN BREAST-CANCER INCIDENCE AND MORTALITY IN DENMARK PRIOR TO MAMMOGRAPHIC SCREENING [J].
ANDREASEN, AH ;
ANDERSEN, KW ;
MADSEN, M ;
MOURIDSEN, H ;
OLESEN, KP ;
LYNGE, E .
BRITISH JOURNAL OF CANCER, 1994, 70 (01) :133-137
[2]  
ANDREASEN AH, 1994, CASE BASED TELEMATIC, P27
[3]   AXILLARY DISSECTION OF LEVEL-I AND LEVEL-II LYMPH-NODES IS IMPORTANT IN BREAST-CANCER CLASSIFICATION [J].
AXELSSON, CK ;
MOURIDSEN, HT ;
ZEDELER, K .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1415-1418
[4]  
Blichert-Toft M, 1998, RECENT RESULTS CANC, V152, P149
[5]   Principles and guidelines for surgeons - Management of symptomatic breast cancer [J].
BlichertToft, M ;
Smola, MG ;
Cataliotti, L ;
OHiggins, N .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (02) :101-109
[6]   PROGNOSIS OF BREAST-CANCER WITH AXILLARY NODE METASTASES AFTER SURGICAL-TREATMENT ONLY [J].
CASCINELLI, N ;
GRECO, M ;
BUFALINO, R ;
CLEMENTE, C ;
GALLUZZO, D ;
DELLEDONNE, V ;
DELELLIS, R ;
SACCHINI, V ;
VERONESI, U .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06) :795-799
[7]  
*DBCG, 1997, DAN BREAST CANC COOP, P1
[8]   Axillary node sampling in breast cancer: an assessment of its efficacy [J].
Dixon, JM ;
Dillon, P ;
Anderson, TJ ;
Chetty, U .
BREAST, 1998, 7 (04) :206-208
[9]   ADJUVANT THERAPY OF PREMENOPAUSAL AND MENOPAUSAL HIGH-RISK BREAST-CANCER PATIENTS - PRESENT STATUS OF THE DANISH-BREAST-CANCER-COOPERATIVE-GROUP TRIALS-77-B AND 82-B [J].
DOMBERNOWSKY, P ;
BRINCKER, H ;
HANSEN, M ;
MOURIDSEN, HT ;
OVERGAARD, M ;
PANDURO, J ;
ROSE, C ;
AXELSSON, CK ;
ANDERSEN, J ;
ANDERSEN, KW .
ACTA ONCOLOGICA, 1988, 27 (6A) :691-697
[10]   Is routine axillary nodal dissection necessary in the treatment of breast cancer? Pro [J].
Fentiman, IS .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) :1460-1461